Novos Obesity Shot Shortfall Shows Danger of Promising Too Much
| 0P00007138 | CAD 54.94 0.18 0.33% |
About 61% of RBC Sciences' investor base is looking to short. The analysis of overall sentiment of trading RBC sciences biologiques fund suggests that many investors are alarmed at this time. The current market sentiment, together with RBC Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use RBC sciences biologiques fund news signals to limit their universe of possible portfolio assets.
RBC |
Novo Nordisk ASs failure to meet its own bar for success on a next-generation obesity shot shows the danger of promising too much in the cut-throat market for weight-loss drugs.
Read at bnnbloomberg.ca
 |
RBC Sciences Fundamental Analysis
We analyze RBC Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RBC Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RBC Sciences based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
One Year Return
One Year Return Comparative Analysis
RBC Sciences is rated below average in one year return among similar funds. One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
RBC sciences biologiques Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with RBC Sciences fund to make a market-neutral strategy. Peer analysis of RBC Sciences could also be used in its relative valuation, which is a method of valuing RBC Sciences by comparing valuation metrics with similar companies.
Peers
RBC Sciences Related Equities
| 0P00007138 | RBC Sciences | 0.33 |
| ||
| 0P00018PVY | RBC European | 1.19 |
| ||
| 0P00007065 | RBC Mondial | 2.28 |
| ||
| 0P00007061 | RBC Canadian | 3.75 |
| ||
| 0P00012UCU | RBC Global | 9.73 |
| ||
| 0P000077P2 | RBC Dividend | 13.84 |
|
Other Information on Investing in RBC Fund
RBC Sciences financial ratios help investors to determine whether RBC Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Sciences security.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |